Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00122629
Status:
TERMINATED
Last Update Posted:
2005-07-29
First Post:
2005-07-20
Brief Title:
Triple Therapy With Peg-Interferon Alfa-2bRibavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2bRibavirin for Previous Hepatitis C Virus HCV Non Responders
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-05
Completion Date Type:
None
First Submit Date:
2005-07-20
First Submit QC Date:
July 20 2005
Study First Post Date:
2005-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2005-07-28
Last Update Post Date:
2005-07-29
Last Update Post Date Type:
ESTIMATED